Search Results - "Karola, Wagner"

The Targeted Immunocytokine L19-IL2 Efficiently Inhibits the Growth of Orthotopic Pancreatic Cancer by WAGNER, Karola, SCHULZ, Petra, SCHOLZ, Arne, WIEDENMANN, Bertram, MENRAD, Andreas

“…Purpose: Effective control of pancreatic cancer has been hampered primarily by the lack of tumor specificity of current treatment modalities. The highly…”
Get full text

Final Results of a Phase I/II Trial of the Combination Bendamustine and Rituximab With Temsirolimus (BeRT) in Relapsed Mantle Cell Lymphoma and Follicular Lymphoma by Hess, Georg, Wagner, Karola, Keller, Ulrich, La Rosee, Paul, Atta, Johannes, Hübel, Kai, Lerchenmueller, Christian, Schoendube, Daniel, Witzens‐Harig, Mathias, Ruckes, Christian, Medler, Christoph, Oordt, Christina, Klapper, Wolfram, Theobald, Matthias, Dreyling, Martin

“…In this phase I/II study, we explored the combination of Temsirolimus with Bendamustine and Rituximab (BeRT) in patients with relapsed or refractory (r/r)…”
Get full text

Activin A stimulates vascular endothelial growth factor gene transcription in human hepatocellular carcinoma cells by Wagner, Karola, Peters, Michael, Scholz, Arne, Benckert, Christoph, Ruderisch, Hugo Sanchez, Wiedenmann, Bertram, Rosewicz, Stefan

“…Background & Aims : Up-regulation of vascular endothelial growth factor is known to play a critical role in hepatocellular tumor biology. In an attempt to…”
Get full text

Temsirolimus in Combination with Bendamustine and Rituximab (BeRT) for the Treatment of Relapsed Mantle Cell and Follicular Lymphoma: Final Phase I/II Results by Hess, Georg, Karola, Wagner, LaRosee, Paul, Keller, Ulrich, Atta, Johannes, Witzens-Harig, Mathias, Crombé, Anne, Medler, Christoph, Borchmann, Peter, Bitz, Ulrich, Lerchenmüller, Christian, Theobald, Matthias, Dreyling, Martin H.

“…Background: mTOR inhibition has been shown to be effective in various subtypes of malignant lymphomas (Smith et al, JCO 2010). Furthermore, in relapsed MCL a…”
Get full text

Temsirolimus in Combination with Bendamustine and Rituximab for the Treatment of Relapsed Mantle Cell and Follicular Lymphoma: Report on an Ongoing Phase I/II Trial by Hess, Georg, Keller, Ulrich, Atta, Johannes, Bitz, Ulrich, Lerchenmueller, Christian, Karola, Wagner, Medler, Christoph, Ruckes, Christian, Witzens-Harig, Mathias, Huebel, Kai, LaRosee, Paul, Dreyling, Martin H.

“…Background: mTOR inhibition has been shown to be effective in various subtypes of malignant lymphomas. In relapsed MCL a phase III trial could prove…”
Get full text

Transforming growth factor β1 stimulates vascular endothelial growth factor gene transcription in human cholangiocellular carcinoma cells by BENCKERT, Christoph, JONAS, Sven, HÖCKER, Michael, ROSEWICZ, Stefan, CRAMER, Thorsten, VON MARSCHALL, Zofia, SCHÄFER, Georgia, PETERS, Michael, WAGNER, Karola, RADKE, Cornelia, WIEDENMANN, Bertram, NEUHAUS, Peter

Get full text

Transforming growth factor beta 1 stimulates vascular endothelial growth factor gene transcription in human cholangiocellular carcinoma cells by Benckert, Christoph, Jonas, Sven, Cramer, Thorsten, Von Marschall, Zofia, Schäfer, Georgia, Peters, Michael, Wagner, Karola, Radke, Cornelia, Wiedenmann, Bertram, Neuhaus, Peter, Höcker, Michael, Rosewicz, Stefan

“…The expression pattern and functional interaction of proangiogenic factors in human cholangiocellular carcinoma (CCC) have not been fully defined. We therefore…”
Get full text

Activin a stimulates VEGF gene transcription in human hepatocellular carcinoma cells by Peters, Michael, Wagner, Karola, Scholz, Arne, Wimmel, Anja, Von Marschall, Zofia, Wiedenmann, Bertram, Rosewicz, Stefan

Get full text